| (MXN) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -19.68M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, INO.MX returned -49.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -32.3% |
| 1 year | -49.0% |
| 5 years | -99.0% |
| All-time high | $7,429.68 (May 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in INO.MX would be worth today ›No. Inovio Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Inovio Pharmaceuticals, Inc. is part of the Healthcare sector.
Inovio Pharmaceuticals, Inc. has a market cap of 2.17B MXN, based on the latest quote.
Inovio Pharmaceuticals, Inc. is expected to report earnings around Nov 10, 2026. That date is an estimate and has not been confirmed by the company.
